Global Innovators Gather for GenScript’s Biotech Forum in San Francisco

GenScript Biotech Corporation is set to host its 5th Annual Biotech Global Forum on January 14, 2026, at the San Francisco Marriott Marquis. This year’s event will provide both in-person and virtual attendance options, reflecting the evolving landscape of biotechnology. The Forum coincides with the J.P. Morgan Healthcare Conference week, a strategic period for industry leaders to converge and discuss advancements in biotechnology.

The theme for this year’s gathering is “Scripting Possibilities,” focusing on how innovations in cell and gene therapies (CGTs) and next-generation biotherapeutics are reshaping the biotech landscape. Key discussions will center on how transformative advancements and computational revolutions redefine possibilities in therapeutic development and discovery.

Sherry Shao, CEO of GenScript Biotech Corp., emphasized the importance of the Global Forum as a pivotal meeting point for scientists, innovators, investors, and decision-makers. “The Global Forum has become a central gathering point for leaders driving progress across the biotech ecosystem,” she stated. Shao highlighted GenScript’s commitment to empowering researchers and companies through integrated technologies, platforms, and expertise, facilitating the journey from discovery to manufacturing.

Keynote Speakers Set to Inspire

The Forum will feature two distinguished keynote speakers whose work bridges biology and artificial intelligence. Their presentations aim to inspire attendees by showcasing the integration of algorithms in molecular design and the impact of AI on scientific progress.

Ray Chen, PhD and President of GenScript Life Science Group, noted, “Biotechnology is at an inflection point – where speed, precision, and collaboration are no longer optional.” Chen added that the Forum is designed to unite leaders who are shaping the future of biotech. He pointed out that the event will explore ways to push the boundaries of what is possible, emphasizing the convergence of discovery science, computational intelligence, and therapeutic development.

Attendees can expect engaging discussions that focus on technologies and collaborations that are accelerating the transition from innovative ideas to tangible patient impact.

Registration for the GenScript Biotech Global Forum is currently open, and interested participants can find more information on GenScript’s official website.

About GenScript Biotech Corporation

Founded in 2002 in New Jersey, GenScript Biotech Corporation plays a crucial role in advancing innovation in biotech and healthcare. The company provides essential resources to researchers and organizations, facilitating the development of groundbreaking treatments and products. Guided by the mission to “Make People and Nature Healthier Through Biotechnology,” GenScript supports customers throughout the innovation lifecycle—from early discovery to advanced biologics and manufacturing.

With a dedicated team of over 5,700 employees, GenScript has served more than 200,000 customers in over 100 countries and regions, solidifying its position as a leader in the biotech sector. For further details, visit GenScript’s website.

Media inquiries can be directed to Stefanie Tuck at CG Life, via email at [email protected].